A Pilot Study to Test Activity of Antimalarial Drugs Against an Induced Malaria Infection in Healthy Volunteers

This study has been completed.

Sponsor:

Collaborators:

Queensland Institute of Medical Research

Q-Pharm Pty Limited

Trident Clinical Research Pty Ltd

Information provided by:

Medicines for Malaria Venture

ClinicalTrials.gov Identifier:

NCT01055002

First received: January 21, 2010

Last updated: June 23, 2011

Last verified: June 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	August 2010
Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)

No publications provided by Medicines for Malaria Venture

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

McCarthy JS, Sekuloski S, Griffin PM, Elliott S, Douglas N, Peatey C, Rockett R, O'Rourke P, Marquart L, Hermsen C, Duparc S, Möhrle J, Trenholme KR, Humberstone AJ. A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS One. 2011;6(8):e21914. Epub 2011 Aug 22.

To Top